Cargando…
Central Nervous System Myeloma and Unusual Extramedullary Localizations: Real Life Practical Guidance
Central nervous system localization of multiple myeloma (CNS-MM) accounts for about 1% of all MM during disease course or even rarer at diagnosis. A difference in the origin, i.e., osteodural or primary dural vs leptomeningeal/intraparenchymal, seems to define two distinct types of intracranial myel...
Autores principales: | Sammartano, Vincenzo, Cerase, Alfonso, Venanzi, Valentina, Mazzei, Maria Antonietta, Vangone, Beatrice Esposito, Gentili, Francesco, Chiarotti, Ivano, Bocchia, Monica, Gozzetti, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300839/ https://www.ncbi.nlm.nih.gov/pubmed/35875104 http://dx.doi.org/10.3389/fonc.2022.934240 |
Ejemplares similares
-
Daratumumab efficacy in extramedullary orbital myeloma
por: Gozzetti, Alessandro, et al.
Publicado: (2020) -
Single Agent Lenalidomide Activity in Multiple Myeloma Relapse Evidenced Uniquely by CT/PET
por: Gozzetti, Alessandro, et al.
Publicado: (2012) -
Anti-BCMA novel therapies for multiple myeloma
por: Sammartano, Vincenzo, et al.
Publicado: (2023) -
Functional Imaging in the Evaluation of Treatment Response in Multiple Myeloma: The Role of PET-CT and MRI
por: Santoni, Adele, et al.
Publicado: (2022) -
A BRAF-Negative Classic Hairy Cell Leukemia Patient with Long-Lasting Complete Remission after Rituximab and Pentostatin
por: Gozzetti, Alessandro, et al.
Publicado: (2020)